Benzinga··Vandana SinghJ&J Wins FDA Clearance for Accelerated Monthly Dosing of Lung Cancer Therapy
J&J's lung cancer therapy Rybrevant Faspro gains FDA approval for accelerated monthly dosing, maintaining efficacy while improving patient convenience and reducing treatment burden.
JNJFDA approvalRybrevant Faspro